Meriyani, H. et al. 2025. Eribulin Effectiveness and Safety in Metastatic Triple-Negative Breast Cancer: A Narrative Review. Borneo Journal of Pharmacy. 8, 1 (Feb. 2025), 33–48. DOI:https://doi.org/10.33084/bjop.v8i1.7913.